Literature DB >> 12018777

Covariate-adjusted response-adaptive designs for binary response.

W F Rosenberger1, A N Vidyashankar, D K Agarwal.   

Abstract

An adaptive allocation design for phase III clinical trials that incorporates covariates is described. The allocation scheme maps the covariate-adjusted odds ratio from a logistic regression model onto [0, 1]. Simulations assume that both staggered entry and time to response are random and follow a known probability distribution that can depend on the treatment assigned, the patient's response, a covariate, or a time trend. Confidence intervals on the covariate-adjusted odds ratio is slightly anticonservative for the adaptive design under the null hypothesis, but power is similar to equal allocation under various alternatives for n = 200. For similar power, the net savings in terms of expected number of treatment failures is modest, but enough to make this design attractive for certain studies where known covariates are expected to be important and stratification is not desired, and treatment failures have a high ethical cost.

Entities:  

Mesh:

Year:  2001        PMID: 12018777

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  13 in total

1.  A Bayesian adaptive design with biomarkers for targeted therapies.

Authors:  Jens C Eickhoff; KyungMann Kim; Jason Beach; Jill M Kolesar; Jason R Gee
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

2.  A Unified Family of Covariate-Adjusted Response-Adaptive Designs Based on Efficiency and Ethics.

Authors:  Jianhua Hu; Hongjian Zhu; Feifang Hu
Journal:  J Am Stat Assoc       Date:  2015-04-22       Impact factor: 5.033

3.  Response-adaptive randomization for clinical trials with adjustment for covariate imbalance.

Authors:  Jing Ning; Xuelin Huang
Journal:  Stat Med       Date:  2010-07-30       Impact factor: 2.373

4.  Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.

Authors:  Yining Du; John D Cook; J Jack Lee
Journal:  J Biopharm Stat       Date:  2017-03-21       Impact factor: 1.051

5.  Simulation study for evaluating the performance of response-adaptive randomization.

Authors:  Yining Du; Xuan Wang; J Jack Lee
Journal:  Contemp Clin Trials       Date:  2014-11-11       Impact factor: 2.226

Review 6.  Challenges and opportunities in biomarker-driven trials: adaptive randomization.

Authors:  Yeonhee Park
Journal:  Ann Transl Med       Date:  2022-09

7.  A simulation study for comparing testing statistics in response-adaptive randomization.

Authors:  Xuemin Gu; J Jack Lee
Journal:  BMC Med Res Methodol       Date:  2010-06-05       Impact factor: 4.615

8.  Can response-adaptive randomization increase participation in acute stroke trials?

Authors:  Jason S Tehranisa; William J Meurer
Journal:  Stroke       Date:  2014-06-10       Impact factor: 7.914

9.  Estimation and testing in targeted goup sequential covariate-adjusted randomized clinical trials.

Authors:  A Chambaz; M J van der Laan
Journal:  Scand Stat Theory Appl       Date:  2013-05-07       Impact factor: 1.396

10.  Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?

Authors:  Sofía S Villar; Jack Bowden; James Wason
Journal:  Pharm Stat       Date:  2017-12-19       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.